doi: 10.3390/ijerph21091152 The ethics of enhancement among image and performance enhancing drug coaches
Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats
2 Wegovy pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep it off
Retatrutide Starts at $375* Retatrutide is an advanced triple-action metabolic therapy designed to support significant weight loss, optimize metabolic function, and enhance overall energy balance by targeting GLP-1, GIP, and glucagon pathways
The take-home message: Don't assume that any food with "GLP-1" in its name or on its label can help if you're taking obesity meds
The tirzepatide versus semaglutide dosage chart lays out the differences clearly
